Details

Autor(en) / Beteiligte

• Verheye, Stefan
• Carrié, Didier
• Khattab, Ahmed
• Slagboom, Ton
• berland, jacques
• Horak, Jan
• Vrolix, Mathias
• Smits, Pieter C
• Legrand, Victor M
• Van Mieghem, Nicolas M
• Fajadet, Jean
• Schofer, Joachim
• Stella, Pieter R

Titel

TCT-599 Final procedural, 30-day and 6-month angiographic, clinical and OCT outcomes from the DIRECT II Trial using the Svelte Integrated Delivery System with Enzymatic Bioabsorbable Sirolimus Coating

Ist Teil von

• Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.B175-B175

Ort / Verlag

New York: Elsevier Inc

Erscheinungsjahr

2014

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Background The Svelte (New Providence, NJ) sirolimus-eluting coronary stent utilizing a bioresorbable amino acid-based (PEA) drug carrier is mounted on a novel Integrated Delivery System (IDS) consisting of a low-compliant balloon with balloon control bands (BCBs) affixed to a 0.014 integrated wire with shapeable tip.